Nonheartbeating Donors

The use of non-heart-beating donors is not a new concept; in fact, it constituted the only method of organ procurement at the beginning of the era of transplantation. In the past few years the use of non-heart-beating donors has witnessed a comeback. In Japan, for social reasons, non-heart-beating donors represent, together with living-related donation, the main source of transplantable organs. In the United States its use represents an adjunctive way of increasing the number of available organs. This method has been mainly reserved for the procurement of kidneys and pancreata although an extension to the utilization of liver and lung grafts has been attempted in some centers.41 The criteria utilized in the selection of these donors are the same described above for the cadaveric donors, the difference being represented by the method of procurement and the longer warm ischemia time.42

The results in a recent report by a center with a large experience with non-heart-beating donors show kidney graft survival at 1 and 2 years of 84% and 76%, respectively and are comparable with the one obtained from heart-beating cadav-

■I eric donors 90% and 85%, respectively.43 Also, in the case of pancreas transplanta-4 tion, good results were obtained with 8 out of 11 patients reaching posttransplant ® insulin independence, when non-heart-beating donors were younger than 55 years, had only 10 minutes of warm ischemia time, and in situ perfusion with cold UW solution.44

The experience with liver procurement from a non-heart-beating donor appears to be promising. The University of Wisconsin was able to increase the number of organs transplanted by 8.6% over a 17-month period. The practice of using such donors should possibly be pursued more aggressively in view of the fact that the survival of these grafts is comparable to the ones from the marginal donors.


1. 1996 Annual Report of the U.S. Scientific Registry for Transplant Recipients and the Organ Procurement and Transplantation Network—Transplant Data: 19881995. UNOS, Richmond, VA, and the Division of Transplantation, Bureau of Health Resources Development, Health Resources and Services Administration, U.S. Department of Health and Human Services, Rockville, MD, page 65.

2. Gonwa TA, Atkins C, Zhang YA et al. Glomerular filtration rates in persons evaluated as living-related donors: Are our standards too high? Transplantation 1993; 55(5):983-985.

3. Heffron TG, Emond JC. Living related liver transplantation. In: Busuttil RW and Klintmalm GB, eds. Transplantation of the Liver. Philadelphia: WS Saunders Publishing Co 1996:518-528.

4. Trinkle JK, Banowsky LHW. Identification and management of organ donors. Texas Medicine 1988; 84:38-43.

5. Penn I. Donor transmitted disease: Cancer. Transplant Proc 1991; 23(5): 2629-2631.

6. Hauptman PJ, OiConner KJ. Procurement and allocation of solid organs for transplantation. N Engl J Med 1997; 336(6):422-431.

7. CDC. Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs. MMWR 1994; 43(RR-8): 1-17.

8. Wachs ME, Amend WJ, Ascher NL et al. Risk of transmission of hepatitis b from HbsAg(-), HbcAb(+), HBIgM(-) organ donors. Transplantation 1995; 59(2):230-234.

9. Harmon WE, Alexander SR, Tejani A et al. The effect of donor age on graft survival in pediatric cadaver renal transplant recipients—A report of the North American pediatric renal transplant cooperative study. Transplantation 1992; 54(2):232-237.

10. Abouna GM, Kumar MSA, Miller LI et al. Combined kidney and pancreas transplantation from pediatric donors into adult diabetic recipients. Transplant Proc 1994; 26(2):441-442.

11. Gruessner RWG, Troppmann C, Barrou B et al. Assessment of donor and recipient risk factors on pancreas transplant outcome. Transplant Proc 1994; 26(2):437-438.

12. Gruessner A, Gruessner R, Moudry-Munns K et al. Influence of multiple factors (age, transplant number, recipient category, donor source) on outcome of pancreas transplantation at one institution. Transplant Proc 1993; 25(1):1303-1305.

13. Brooks BK, Levy MF, Jennings LW et al. Influence of donor and recipient gender on the outcome of liver transplantation. Transplantation 1996; 62(12):1784-1787.

14. Marino IR, Doyle HR, Aldrighetti L et al. Effect of donor age and sex on the outcome of liver transplantation. Hepatology 1995; 22(6):1754-1762.

15. Neugarten J, Silbiger SR. The impact of gender on renal transplantation. Transplantation 1994; 58(11):1145-1152.

16. de Ville de Goyet J and Otte JB. Cut-down and split liver transplantation. In: Busuttil RW and Klintmalm GB, eds. Transplantation of the Liver. Philadelphia: WS Saunders Publishing Co., 1996:481-496.

17. DiAlessandro AM, Kalayoglu M, Sollinger HW et al. The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. Transplantation 1991; 51(1):157-163.

18. Fishbein TM, Fiel MI, Emre S et al. Use of livers with microvesicular fat safely expands the donor pool. Transplantation 1997; 64(2):248-251.

19. Busson M, NiDoye P, Benoit G et al. Donor factors influencing organ transplant programs. Transplant Proc 1995; 27(2):1662-1664.

20. Greig PD, Forster J, Superina RA et al. Donor-specific factors predict graft function following liver transplantation. Transplant Proc 1990; 22(4):2072-2073.

21. Gruessner AC, Barrou B, Jones J et al. Donor impact on outcome of bladder-drained pancreas transplants. Transplant Proc 1993; 25(6):3114-3115.

22. Alexander JW, Zola JC. Expanding the donor pool: Use of marginal donors for solid organ transplantation. Clin Transplantation 1996; 10:1-19.

23. Testa G, Goldstein RM, Netto G et al. Long-term outcome of patients transplanted with liver from hepatitis C-positive donors. Transplantation 1998; 65(7):925-929.

24. Krishnan G, Vaughn WK, Capelli JP et al. Positive donor/recipient CMV status is not a detrimental factor for renal allograft/patient survival. Transplant Proc 1993; 25(1):1485-1486.

25. Schnitzler MA, Woodward RS, Brennan DC et al. The effects of cytomegalovirus serology on graft and recipient survival in cadaveric renal transplantation: Implications for organ allocation. Am J Kidney Dis 1997; 29(3):428-434.

26. Mor E, Klintmalm GB, Gonwa TA et al. The use of marginal donors for liver transplantation. A retrospective study of 365 liver donors. Transplantation 1992; 53(2):383-386.

27. Oellerich M, Burdelski M, Ringe B et al. Functional state of the donor liver and early outcome of transplantation. Transplant Proc 1991; 23(1):1575-1578.

28. Hesse UJ, Gores PF, Sutherland DER. Serum amylase and plasma glucose levels in pancreas cadaver donors: correlation with functional status of the pancreatic graft. Transplant Proc 1989; 21:2765-2766.

29. Gores PF, Gillingham KJ, Dunn DL et al. Donor hyperglycemia as a minor risk factor and immunologic variables as major risk factors for pancreas allograft loss in a multivariate analysis of a single institutions experience. Ann Surg 1992; 215(3):217-230.

30. Shaffer D, Madras PN, Sahyoun AI et al. Cadaver donor hyperglycemia does not impair long-term pancreas allograft survival or function. Transplant Proc 1994; 26(2):439-440.

31. Douzdjian V, Gugliuzza KG, Fish JC. Multivariate analysis of donor risk factors for pancreas allograft failure after simultaneous pancreas-kidney transplantation. Surgery 1995; 118(1):73-81.

32. Leikin JB, Heyn-Lamb R, Aks S et al. The toxic patient as a potential organ donor. AM J Emerg Med 1994; 12(2):151-154.

33. Alexander JW, Vaughn WK. The use of imarginalî donors for organ transplantation. The influence of donor age on outcome. Transplantation 1991; 51(1):135-141.

34. Alexander JW, Vaughn WK, Carey MA. The use of marginal donors for organ transplantation: The older and younger donors. Transplant Proc 1991; 23(1):905-909.

35. Makowka L, Gordon RD, Todo S et al. Analysis of donor criteria for the prediction of outcome in clinical liver transplantation. Transplant Proc 1987; 19(1):2378-2382.

36. Hoofnagle JH, Lombardero M, Zetterman RK et al. Donor age and outcome of liver transplantation. Hepatology 1996; 24(1):89-96.

37. Johnson LB, Kuo PC, Schweitzer EJ et al. Double renal allografts successfully increase utilization of kidneys from older donors within a single organ procurement organization. Transplantation 1996; 62(11):1581-1583.

38. Webb MG, Tzakis AG, Olson L. Donor small bowel procurement. In: Phillips MG, ed. UNOS Organ Procurement, Preservation and Distribution in Transplantation. 2nd ed. Richmond: UNOS, 1996:139-143.

39. Sindhi R, Fox IJ, Heffron T et al. Procurement and preparation of human isolated small intestinal grafts for transplantation. Transplantation 1995; 60(8):771-773.

40. Langnas AN, Shaw BW Jr., Antonson DL et al. Preliminary experience with intestinal transplantation in infants and children. Pediatrics 1996; 97(4):443-448.

41. D'Alessandro AM, Hoffmann RM, Knechtle SJ et al. Controlled non-heart-beating donors: A potential source of extrarenal organs. Transplant Proc 1995; 27(1):707-709.

42. Eckhoff DE, D'Alessandro AM. The non-heartbeating donor. In: Phillips MG, ed. UNOS Organ Procurement, Preservation and Distribution in Transplantation. 2nd ed. Richmond: UNOS, 1996:183-189.

43. Hattori R, Kinukawa T, Ohshima S et al. Outcome of kidney transplantation from non-heart-beating donors: Comparison with heart-beating donors. Transplant Proc 1992; 24(4):1455-1456.

44. Teraoka S, Babazono T, Tomonaga O et al. Donor criteria and technical aspects of procurement in combined pancreas and kidney transplantation from non-heart-beating cadavers. Transplant Proc 1995; 27(6):3097-3100.

Was this article helpful?

0 0

Post a comment